About the Journal

About the Journal

Georgian Medical Journal

Public Health Institute of Georgia (PHIG) · ISSN 3088-4322 · DOI prefix 10.66636 · Open Access · CC BY 4.0

The Georgian Medical Journal (GMJ) is an independent, peer-reviewed, open-access journal published by the Public Health Institute of Georgia (PHIG). GMJ publishes scholarly work across clinical medicine, surgery, public health, epidemiology, health systems and management, quality and patient safety, medical education, bioethics, and health policy, with particular relevance to Georgia and the wider region.

The journal maintains full editorial independence from its publisher, sponsors, advertisers, and other financial interests.

Quarterly · Georgian & English · Double-anonymised peer review · Open Access · CC BY 4.0
About the Journal → Author Guidelines → Submit a Manuscript →

Homepage journal summary last reviewed and updated: September 2026.

Announcements

Current Issue

Vol. 1 No. 4 (2026): Vol. 1 No. 4 (2026): Cardiovascular Health, Clinical Pharmacology, and Emerging Medical Technologies
GMJ Volume 1, Issue 4 (2026) cover: Cardiovascular Health, Clinical Pharmacology, and Emerging Medical Technologies.

Georgian Medical Journal (GMJ) · Volume 1 · Issue 4 · 2026

Volume 1, Issue 4 of the Georgian Medical Journal (GMJ) brings together contemporary research and clinical perspectives across cardiovascular and cardiometabolic health, clinical pharmacology, neurology, endocrinology and women’s health, patient safety, and emerging medical technologies.

Modern medicine increasingly requires clinicians and researchers to work across traditional disciplinary boundaries. Cardiovascular disease intersects with metabolic disorders; increasingly complex pharmacotherapy requires careful consideration of drug interactions and patient safety; neurological and functional symptoms demand multidisciplinary approaches; and artificial intelligence and digital technologies are creating new opportunities for diagnosis, risk assessment, and clinical decision-making.

This issue reflects these connections and GMJ’s commitment to bringing together clinical evidence, public health relevance, patient-centred practice, and medical innovation.

Scope of This Issue

Cardiovascular and Cardiometabolic Health
Research addressing hypertension, diabetes, cardiovascular risk, myocardial infarction, prevention, early detection, and the burden of cardiometabolic disease in clinical and community settings.

Clinical Pharmacology and Complex Pharmacotherapy
Contemporary approaches to medication management, polypharmacy, multidisciplinary clinical pharmacology, therapeutic decision-making, and the rational and safe use of medicines.

Drug Interactions and Patient Safety
Research examining pharmacokinetic interactions, drug–drug and drug–herb interactions, complementary medicines, perioperative considerations, and strategies for reducing medication-related harm.

Neurology and Functional Disorders
Clinical perspectives on somatic symptoms, functional neurological disorders, neurological presentations in outpatient practice, and multidisciplinary approaches to diagnosis and management.

Endocrinology and Women’s Health
Research exploring endocrine and metabolic conditions affecting women’s health, including polycystic ovary syndrome and the complex relationships between hormonal, metabolic, and reproductive health.

Artificial Intelligence and Emerging Medical Technologies
Applications of artificial intelligence, machine learning, digital health, and emerging technologies in diagnosis, risk stratification, prediction, clinical decision support, and healthcare delivery.

Rural and Population Health
Research examining cardiometabolic disease, risk factors, prevention, early detection, health inequalities, and access to healthcare in rural and community populations, including evidence generated in Georgia.

Clinical Practice and Patient Safety
Research and clinical perspectives focused on translating scientific evidence into safer, more effective, accessible, and patient-centred healthcare.

From Clinical Evidence to Emerging Technology

Healthcare is undergoing rapid transformation. Advances in diagnostic technologies, artificial intelligence, pharmacology, and data-driven medicine are expanding the possibilities of clinical practice. At the same time, the fundamental challenges of medicine remain: preventing disease, identifying risk early, making accurate diagnoses, selecting appropriate treatments, protecting patients from avoidable harm, and ensuring that scientific advances translate into better health outcomes.

The articles presented in this issue illustrate different dimensions of this evolving landscape — from cardiovascular and cardiometabolic health to complex pharmacotherapy, neurological and endocrine conditions, patient safety, and the application of artificial intelligence in medicine.

By bringing these areas together, GMJ seeks to create a bridge between established clinical practice and emerging medical innovation, while providing an international platform for research from Georgia and the wider scientific community.

About the Georgian Medical Journal

The Georgian Medical Journal (GMJ) is an international, peer-reviewed, open-access scientific journal committed to advancing high-quality research across medicine, public health, healthcare systems, biomedical sciences, medical education, quality and patient safety, and emerging health technologies.

GMJ provides a platform for researchers, clinicians, public health professionals, educators, and other health professionals from Georgia and internationally to communicate research that contributes to scientific knowledge and improved health.

The journal is committed to scientific integrity, methodological quality, editorial independence, transparency, international collaboration, and open access to knowledge.

Submissions

The Georgian Medical Journal welcomes:

Original Research Articles · Systematic Reviews and Meta-Analyses · Narrative and Scoping Reviews · Case Reports and Case Series · Short Communications · Clinical and Public Health Analyses · Policy Analyses · Expert Perspectives · Commentaries · Editorials

All manuscripts undergo editorial assessment and, where appropriate, independent peer review in accordance with GMJ editorial policies.

Publication Information

Journal: Georgian Medical Journal (GMJ)
Volume: 1
Issue: 4
Year: 2026
ISSN: 3088-4322
DOI prefix: 10.66636
Publisher: Public Health Institute of Georgia (PHIG)
Access: Open Access
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Website: gmj.ge

Public Health Institute of Georgia (PHIG) · ISSN 3088-4322 · DOI prefix: 10.66636 · Open Access · CC BY 4.0 · gmj.ge

Published: 09/16/2026
View All Issues

Welcome from the Editor-in-Chief

Dear colleagues, friends, and readers,

It is my great pleasure to welcome you to the Georgian Medical Journal (GMJ)—an independent, peer-reviewed, open-access platform dedicated to advancing health and healthcare across Georgia and our wider region. Since our launch in January 2025, GMJ has grown rapidly into a globally connected scholarly journal, now indexed in 21 international databases and a full Crossref member (DOI prefix: 10.66636).

GMJ was founded by the Public Health Institute of Georgia (PHIG) with a simple promise: rigour, integrity, and relevance. We publish across the full spectrum of medicine—clinical and surgical sciences; social medicine; health management; quality and patient safety; public/international (global) health; and traditional/complementary medicine aligned with World Health Organization (WHO) frameworks. Our editorial independence is non-negotiable; decisions are based solely on scientific merit and ethical standards.

From 5 January 2025 to 1 January 2027, all accepted articles are published under a 100% PHIG Publication Grant—completely free for every author, with no application required. From 1 January 2027, we maintain transparent, modest fees with strong waivers and an expanding PHIG Publication Grant programme to support unfunded and public-sector research.

We expect methodological clarity, ethical compliance, and transparency. Submissions should follow established reporting guidelines (CONSORT, STROBE, PRISMA, CARE, SQUIRE). Every published item receives a Digital Object Identifier (DOI) via Crossref (prefix 10.66636) and is preserved through trusted archiving networks including CLOCKSS and the PKP Preservation Network. We welcome manuscripts in Georgian and English and encourage plain-language summaries where appropriate to bridge research and practice.

GMJ is also a home for translation and dialogue: editorials, viewpoints, explainers for the public, and conference outputs that turn evidence into action. The GMJ Official Podcast, available on Spotify, Apple Podcasts, YouTube, Amazon Music, Castbox, Goodpods, and Pocket Casts, extends our scholarly conversations beyond the printed page. We aim to be a meeting point for clinicians, educators, managers, policymakers, and communities.

To early-career researchers, mentors, reviewers, and partners—thank you. Your curiosity, critical insight, and generosity continue to shape this journal's culture. I invite you to read, review, submit, and challenge us to do better.

On behalf of the editorial team, welcome to GMJ. Let us build a journal that measurably improves care, strengthens health systems, and elevates Georgia's voice in global medicine.

With respect,

Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal (GMJ)
Public Health Institute of Georgia (PHIG) · editor@gmj.ge · gmj.ge